MedTrace Logo

Efficacy of Ciclesonide During the Cold Season in Patients Older Than 12 Years With Persistent Asthma

NCT00608218 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 2100

Last updated 2016-12-05

No results posted yet for this study

Summary

The aim of the study is to evaluate the efficacy of ciclesonide in patients with persistent asthma over 3 months, especially in the cold season. Ciclesonide will be inhaled by a metered-dose inhaler. The study will provide further data on safety and tolerability of ciclesonide.

Conditions

Interventions

DRUG

Ciclesonide

This is an observational study. Therefore, the physician decides about dosage according to individual needs.

Sponsors & Collaborators

Principal Investigators

  • AstraZeneca AstraZeneca · AstraZeneca

Eligibility

Min Age
12 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-01-31
Primary Completion
2008-08-31
Completion
2008-08-31

Countries

  • Germany

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00608218 on ClinicalTrials.gov